FDA Approved: ROFLUMILAST — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for roflumilast filed by Aurobindo Pharma Limited under ANDA213298, enabling a generic roflumilast product to enter …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

SUPPL AP for ROFLUMILAST (ROFLUMILAST)